Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2007

01-10-2007 | Review Paper

Provider’s volume and quality of breast cancer detection and treatment

Authors: Nicole Hébert-Croteau, Danièle Roberge, Jacques Brisson

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access

Abstract

For many health conditions, the process or result of medical procedures improves with increasing caseload. The evidence about breast cancer has not been thoroughly assessed. This review synthesizes the literature about provider’s volume and performance in either breast cancer screening with mammography or treatment. Articles published in English between 1990 and 2006 were identified by a computerized search and by review of reference lists. In screening with mammography, the reading volume of the radiologist and the screening volume of the facility influence different components of performance. The most conclusive evidence for breast cancer treatment concerns the association between the surgeon’s caseload and the process or end-results of therapeutic interventions. Although the mechanisms of these associations still need to be clarified, large provider’s volume in screening mammography or breast cancer treatment is often related to the quality of medical interventions.
Literature
1.
Hillner BE, Smith TJ, Desch CE (2000) Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality cancer care. J Clin Oncol 18:2327–2340PubMed
2.
3.
Hébert-Croteau N, Brisson J, Pineault R (2000) Review of organizational factors related to care offered to women with breast cancer. Epi Rev 22:228–238
4.
Malin JL, Schuster MA, Kahn KA et al (2002) Quality of breast cancer care: what do we know? J Clin Oncol 20:4381–4393PubMedCrossRef
5.
Halm EA, Lee C, Chassin MR (2002) Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 137:511–520PubMed
6.
Birkmeyer JD, Stukel TA, Siewers AE et al (2003) Surgeon volume and operative mortality in the United States. New Engl J Med 349:2117–2127PubMedCrossRef
7.
Luft HS, Hunt SS, Maerki SC (1987) The volume-outcome relationship: practice-makes-perfect or selective referral patterns? HSR 22:157–182PubMed
8.
Lipscomb J (2006) Transcending the volume-outcome relationship in cancer care. J Natl Cancer Inst 98:151–154PubMed
9.
Hébert-Croteau N, Brisson J, Latreille J et al (2004) Compliance with consensus recommendations for treatment improves survival of women with node-negative breast cancer. J Clin Oncol 22:3685–3693PubMedCrossRef
10.
Hébert-Croteau N, Brisson J, Lemaire J et al (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104:1343–1348PubMedCrossRef
11.
Birkmeyer NJO, Goodney PP, Stukel TA et al (2005) Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103:435–441PubMedCrossRef
12.
Elmore JG, Wells CK, Howard DH (1998) Does diagnostic accuracy in mammography depend on radiologist’s experience? J Women’s Health 7:443–449CrossRef
13.
Ciatto S, Ambrogetti D, Catarzi S et al (1999) Proficiency test for screening mammography: results for 117 volunteer Italian radiologists. J Med Screen 6:149–151PubMed
14.
Kan L, Olivotto IA, Warren Burhenne LJ et al (2000) Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. Radiology 215:563–567PubMed
15.
Yankaskas BC, Cleveland RJ, Schell MJ et al (2001) Association of recall rates with sensitivity and positive predictive values of screening mammography. AJR 177:543–549PubMed
16.
Blanks RG, Bennett RL, Wallis MG et al (2002) Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme. J Med Screen 9:11–14PubMedCrossRef
17.
Esserman L, Cowley H, Eberle C et al (2002) Improving the accuracy of mammography: volume and outcome relationship. J Natl Cancer Inst 94:369–375PubMed
18.
Beam CA, Conant EF, Sickles EA (2003) Association of volume and volume-independent factors with accuracy in screening mammography interpretation. J Natl Cancer Inst 95:282–290PubMed
19.
Barlow WE, Chi C, Carney PA et al (2004) Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst 96:1840–1850PubMedCrossRef
20.
Théberge I, Hébert-Croteau N, Langlois A et al (2005) Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening program. CMAJ 172:195–199PubMed
21.
Smith-Bindman R, Chu P, Miglioretti DL et al (2005) Physician predictors of mammographic accuracy. J Natl Cancer Inst 97:358–367PubMed
22.
Rickard M, Taylor R, Page A et al (2006) Cancer detection and mammography volume of radiologists in a population-based screening programme. The Breast 15:39–43PubMedCrossRef
23.
Coldman AJ, Major D, Doyle GP et al. (2006) Organized breast screening programs in Canada: effect of radiologist reading volumes on outcomes. Radiology 238:809–815PubMedCrossRef
24.
Moss SM, Blanks RG, Bennett RL (2005) Is radiologists’ volume of mammography reading related to accuracy? A critical review of the literature. Clin Radiol 60:623–626PubMedCrossRef
25.
Sickles EA, Wolverton DE, Dee KE (2002) Performance parameters for screening and diagnostic mammography: specialist and general radiologist. Radiology 224:861–869PubMedCrossRef
26.
Elmore JG, Carney PA (2002) Does practice make perfect when interpreting mammography? J Natl Cancer Inst 94:321–323PubMed
27.
Elmore JG, Miglioretti DL, Carney PA (2003) Does practice make perfect when interpreting mammography? Part II. J Natl Cancer Inst 95:250–252PubMed
28.
Egglin TK, Feinstein AR (1996) Context bias. A problem in diagnostic radiology. JAMA 276:1752–1755PubMedCrossRef
29.
Allgood PC, Bachmann MO (2006) Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study. Br J Cancer 94:36–42PubMedCrossRef
30.
Boffetta P, Merletti F, Winkelmann R et al (1993) Survival of breast cancer patients from Piedmont, Italy. Cancer Causes Control 4:209–215PubMed
31.
Bonett A, Roder D, Esterman A (1991) Case-survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia. Med J Aust 154:695–697PubMed
32.
Grilli R, Mainini F, Penna A et al (1993) Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health 83:1762–1764PubMed
33.
Grilli R, Repetto F (1995) Variation in use of breast-conserving surgery in Lombardia, Italy. Int J Technol Assess Health Care 11:733–740PubMedCrossRef
34.
Guadagnoli E, Weeks JC, Shapiro CL et al (1998) Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 16:101–106PubMed
35.
Guadagnoli E, Shapiro CL, Weeks JC et al (1998) The quality of care for treatment of early stage breast carcinoma. Cancer 83:302–309PubMedCrossRef
36.
Guller U, Safford S, Pietrobon R et al (2005) High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 29:994–1000PubMedCrossRef
37.
Hébert-Croteau N, Brisson J, Latreille J et al (1999) Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951–955PubMed
38.
Hébert-Croteau N, Brisson J, Latreille J et al (1999) Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104–1113PubMedCrossRef
39.
Hand R, Sener S, Imperato J et al (1991) Hospital variables associated with quality of care for breast cancer patients. JAMA 266:3429–3432PubMedCrossRef
40.
Harcourt KF, Hicks KL (2003) Is there a relationship between case volume and survival in breast cancer? Am J Surg 185:407–410PubMedCrossRef
41.
Hillner BE, Penberthy L, Desch CE et al (1996) Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat 40:75–86PubMedCrossRef
42.
Hiotis K, Ye W, Sposto R et al (2005) Predictors of breast conservation therapy—Size is not all that matters. Cancer 103:892–899PubMedCrossRef
43.
Hynes DM (1994) The quality of breast cancer care in local communities: implications for health care reform. Med Care 32:328–340PubMedCrossRef
44.
Hynes DM, Weaver F, Morrow M et al (2004) Breast cancer surgery trends and outcomes: results from a National Department of Veterans Affairs study. J Am Coll Surg 198:707–716PubMedCrossRef
45.
Iscoe NA, Goel V, Wu K et al (1994) Variation in breast cancer surgery in Ontario. Can Med Assoc J 150:345–352
46.
Johantgen ME, Coffey RM, Harris DR et al (1995) Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery. Am J Public Health 85:1432–1434PubMed
47.
Kotwall CA, Covington DL, Rutledge R et al (1996) Patient, hospital, and surgeon factors associated with breast conservation surgery. Ann Surg 224:419–429PubMedCrossRef
48.
Lee-Feldstein A, Anton-Culver H, Feldstein PJ (1994) Treatment differences and other prognostic factors related to breast cancer survival. JAMA 271:1163–1168PubMedCrossRef
49.
Ma M, Bell J, Campbell SB et al (1997) Breast cancer management: is volume related to quality? Br J Cancer 75:1652–1659PubMed
50.
McKee MD, Cropp MD, Hyland A et al (2002) Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 95:704–712PubMedCrossRef
51.
Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. New Engl J Med 326:1102–1107PubMedCrossRef
52.
Nattinger AB, Gottlieb MS, Hoffman RG et al (1996) Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care 34:479–489PubMedCrossRef
53.
Roohan PJ, Bickell NA, Baptiste MS et al (1998) Hospital volume differences and five-year survival from breast cancer. Am J Public Health 88:454–457PubMed
54.
Satariano ER, Swanson GM, Moll PP (1992) Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health 82:195–198PubMed
55.
Scorpiglione N, Nicolucci A, Grilli R et al (1995) Appropriateness and variation of surgical treatment of breast cancer in Italy: when excellence in clinical research does not match with generalized good quality care. J Clin Epidemiol 48:345–352PubMedCrossRef
56.
Skinner KA, Helsper JT, Deapen D et al (2003) Breast cancer: do specialists make a difference? Ann Surg Oncol 10:606–615PubMedCrossRef
57.
Stefoski Mikeljevic J, Haward RA, Johnston C et al (2003) Surgeon workload and survival from breast cancer. Br J Cancer 89:487–491PubMedCrossRef
58.
Tanaka H, Hiyama T, Hanai A et al (1994) Interhospital differences in cancer survival: magnitude and trend in 1975–1987 in Osaka, Japan. Jpn J Cancer Res 85:680–685PubMed
59.
Taylor R, Stubbs JM, Langlands AO et al (1999) Predictors of mastectomy for women with breast cancer in the Greater Western Region of Sydney. The Breast 5:116–121CrossRef
60.
Ahn H-S, Yoon S-J, Jo H-Y et al (2006) Association between unplanned readmission rate and volume of breast cancer operation cases. Int J Clin Pract 60:32–35PubMedCrossRef
61.
Shen N, Mayo NE, Scott SC et al (2003) Factors associated with pattern of care before surgery for breast cancer in Quebec between 1992 and 1997. Medical Care 41:1353–1366PubMedCrossRef
62.
Garreau JR, Nelson J, Cook D et al (2005) Geographic variation in sentinel node adaptation br practicing surgeons in Oregon. Am J Surg 189:616–620PubMedCrossRef
63.
Legorreta AP, Liu X, Parker RG (2000) Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol 23:438–441PubMed
64.
Simunovic M, Thériault M-E, Paszat L et al (2005) Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993–2000. Can J Surg 48:137–142PubMed
65.
Jubelirer SJ, Harpold R, Miller S et al (2001) An analysis of factors determining the use of breast conserving surgery for treating early-stage breast cancer. W V Med J 97:144–147PubMed
66.
Byrne MJ, Jamrozik K, Parsons RW et al (1993) Breast cancer in Western Australia in 1989. II. Diagnosis and primary management. Aust N Z J Surg 63:624–629PubMed
67.
Dixon JM, Ravisekar O, Cunningham M et al (1996) Factors affecting outcome of patients with impalpable breast cancer detected by breast screening. Br J Surg 83:997–1001PubMedCrossRef
68.
Ferguson CM, Feinstein AC, Pendergrast WJ (1990) Determinants of primary therapy of early stage breast cancer. J of MAG 79:351–354
69.
Goy JCM, Dobbs HJ, Henderson S et al (1998) Variation in referral pattern for postoperative radiotherapy of patients with screen-detected breast cancer in the South Thames (East) region. Clin Oncol 10:24–29CrossRef
70.
Hislop TG, Olivotto IA, Coldman AJ et al (1996) Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Revue Canadienne de Santé Pub 87:390–394
71.
Ingram DM, McEvoy SP, Byrne MJ et al (2005) Surgical caseload and outcomes for women with invasive breast cancer treated in Western Australia. The Breast 14:11–17PubMedCrossRef
72.
Luther SL, Studnicki J (2001) Physician practice volume and alternative surgical treatment for breast cancer in Florida. HSR 36:166–179PubMed
73.
Moritz S, Bates T, Henderson SM et al (1997) Variation in management of small invasive breast cancers detected on screening in the former South East Thames region: observational study. BMJ 315:1266–1272PubMed
74.
Neuner JM, Gilligan MA, Sparapani R et al (2004) Decentralization of breast cancer surgery in the United States. Cancer 101:1323–1329PubMedCrossRef
75.
Olivotto IA, Coldman AJ, Hislop TG et al (1997) Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 15:216–222PubMed
76.
Porter GA, McMulkin-Tait H (2004) Practice patterns in breast cancer surgery: Canadian perspective. World J Surg 28:80–86PubMedCrossRef
77.
Sainsbury R, Haward B, Rider L et al (1995) Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345:1265–1270PubMedCrossRef
78.
Staradub VL, Hsieh Y-C, Clauson J et al (2002) Factors that influence surgical choices in women with breast carcinoma. Cancer 95:1185–1190PubMedCrossRef
79.
Stevenson JM, Bochenek P, Jamrozik K et al (1997) Breast cancer in Western Australia in 1989 V: Outcome at 5 years after diagnosis. Aust N Z J Surg 67:250–255PubMed
80.
Twelves CJ, Thomson CS, Dewar JA et al (1998) Variation in the survival of women with breast cancer in Scotland. Br J Cancer 78:566–571PubMed
81.
Twelves CJ, Thomson CS, Dewar JA et al (2001) Variation in survival of women with breast cancer: Health Board remains a factor at 10 years. Br J Cancer 85:637–640PubMedCrossRef
82.
White V, Pruden M, Giles G et al (2004) The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 101:476–485PubMedCrossRef
83.
Mor V, Laliberte LL, Petrisek AC et al (2000) Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention. Surgery 128:847–861PubMedCrossRef
84.
Najafi M, Ebrahimi M, Kaviani A et al (2005) Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran. BMC Cancer 5:35–39PubMedCrossRef
85.
Posther KE, McCall LM, Blumencranz PW et al (2005) Sentinel node skills verification and surgeon performance- Data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 242:593–602PubMed
86.
Hislop TG, Coldman AJ, Olivotto IA et al (2003) Local and regional therapy for women with breast cancer in British Columbia. The Breast 9:192–199CrossRef
87.
Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717CrossRef
88.
Hébert-Croteau N, Brisson J, Lemaire J et al (2005) The benefit of participating to clinical research. Breast Cancer Res Treat 91:279–281PubMedCrossRef
89.
Smith TJ, Hillner BE, Bear HD (2006) Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag? J Natl Cancer Inst 95:695–698
90.
Meyer AD, Tsui AS, Hinings CR (1993) Configurational approaches to organisational analysis. Acad Manage J 36:1175–1195CrossRef
Metadata
Title
Provider’s volume and quality of breast cancer detection and treatment
Authors
Nicole Hébert-Croteau
Danièle Roberge
Jacques Brisson
Publication date
01-10-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9439-x

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue

Epidemiology

Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study

Research Paper

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Epidemiology

Breast cancer risk factors and second primary malignancies among women with breast cancer

Review

Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature

Epidemiology

Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients

Preclinical Study

Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits